Artivion (AORT) vs CONMED (CNMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CONMED (CNMD) has outperformed Artivion (AORT) over the past year, losing 3.6% versus a loss of 46.7%. Over five years, AORT leads with a +1.2% price change compared with -68.9% for CNMD. CONMED is the larger company by market cap ($1.34 billion vs $1.04 billion), about 1.3 times the size.
On valuation, CONMED trades at a lower forward P/E (9.4x vs 28.4x for Artivion). CONMED pays a dividend yielding 0.45%, while Artivion does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AORT | CNMD |
|---|---|---|
| Share price | $21.29 | $44.75 |
| Market cap | $1.04B | $1.34B |
| 1-day change | -1.50% | +1.18% |
| YTD return | -52.62% | +8.94% |
| 1-year return | -46.66% | -3.64% |
| 5-year return | +1.17% | -68.86% |
| P/E ratio (TTM) | — | 24.19 |
| Forward P/E | 28.44 | 9.36 |
| EPS (TTM) | $-0.07 | $1.85 |
| Dividend yield | 0.00% | 0.45% |
| Annual dividend | $0.00 | $0.20 |
| 52-week high | $48.25 | $53.66 |
| 52-week low | $19.16 | $31.44 |
| Distance from 52-week high | -55.89% | -16.60% |
| Analyst consensus | none | none |
| Avg. price target upside | +98.03% | +1.68% |
| Average volume | 634.11K | 493.66K |
| Shares outstanding | 48.76M | 29.95M |
| Employees | 1,800 | 3,900 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CNMD has outperformed AORT by 43.0 percentage points over the past year.
About Artivion
AORT stock →Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
Health Care · Medical/Dental Instruments · 1,800 employees
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,900 employees
AORT vs CNMD FAQ
Which is bigger, Artivion or CONMED?
CONMED (CNMD) is larger, with a market capitalization of $1.34B compared with $1.04B for Artivion (AORT).
Which stock has performed better over the past year, AORT or CNMD?
CNMD returned -3.64% over the past 12 months, compared with -46.66% for AORT (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Artivion or CONMED?
CONMED pays a dividend yielding 0.45%, while Artivion does not currently pay a regular dividend.
Are Artivion and CONMED in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Artivion and Biotechnology: Electromedical & Electrotherapeutic Apparatus for CONMED.